Clinical Trial Update: Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management [Phase 2]

View source ↗

Summary

This Phase 2 trial update investigates 3-year disease-free survival in locally advanced rectal cancer patients treated with chemoradiation and induction or cons…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Rectal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING